Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$48.11 USD
+0.49 (1.03%)
Updated Aug 23, 2024 04:00 PM ET
Pre-Market: $48.12 +0.01 (0.02%) 8:56 AM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/24/2024
Time: -- |
9/2024 | $1.58 | -0.08% |
Earnings Summary
For their last quarter, Bristol Myers Squibb (BMY) reported earnings of $2.07 per share, beating the Zacks Consensus Estimate of $1.64 per share. This reflects a positive earnings surprise of 26.22%. Look out for BMY's next earnings release expected on October 24, 2024. For the next earning release, we expect the company to report earnings of $1.58 per share, reflecting a year-over-year decrease of 21%.
Earnings History
Price & Consensus
Zacks News for BMY
Bristol Myers' (BMY) HCC Combo Drug Accepted for FDA Review
BMY: What are Zacks experts saying now?
Zacks Private Portfolio Services